ArticleBMC musculoskeletal disorders2026
Cystic echinococcosis in Austria 2009-2024: national surveillance and two rare cases of musculoskeletal manifestations including clinical management strategies.
Article in BMC musculoskeletal disorders, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundCystic echinococcosis (CE), caused by Echinococcus granulosus, is a parasitic disease that predominantly involves the liver and the lungs, whereas primary involvement of the musculoskeletal system is rare and diagnostically challenging. This study examines isolated musculoskeletal echinococcosis (MSKE) through two uncommon cases treated at an Austrian tertiary centre and proposes a tailored diagnostic and therapeutic approach. To contextualise their rarity, national epidemiological data on CE in Austria over a 15-year period are also presented.
methodsWe queried our institutional database for cases of MSKE managed at an Austrian tertiary orthopaedic centre (2002-2024) and present these as case reports. In addition, we analysed all nationally reported cases of CE in Austria (2009-2024) using data from the electronic epidemiological reporting system.
resultsTwo patients with MSKE were treated at our centre. A 34-year-old Syrian woman presented with a slowly enlarging thigh mass, while a 53-year-old Turkish woman developed recurrent bilateral sacroiliac joint involvement 16 years following surgical resection of a primary hydatid cyst. In both cases, disease was confined to the musculoskeletal system. A total of 323 CE cases from all anatomical sites were included (median age 38 years, IQR 27-52; 50.8% male). Among cases with known infection origin, 53.6% were imported, and among those with available sample data, 81.2% were diagnosed via serum. The annual case count peaked in 2017 (n = 40) and was lowest in 2009, 2012, and 2015 (n = 4 each). A significant temporal trend was observed over 2009-2024 (p = 0.006).
conclusionHydatid cysts should be considered in the differential diagnosis of patients presenting with slow-growing musculoskeletal masses, particularly when initial imaging and clinical history suggest a parasitic aetiology. When localised, complete surgical excision with removal of the intact cyst is curative. Systemic anthelmintic treatment is administered perioperatively or as a conservative option in patients who are not suitable candidates for surgery.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.